Cargando…
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis
INTRODUCTION: Tamoxifen is a selective estrogen receptor modulator widely used in the treatment of breast cancer. Tamoxifen therapy is associated with lower circulating low-density lipoprotein cholesterol and increased triglycerides, but its effects on other lipids are less well studied. AIMS: We ai...
Autores principales: | Sahebkar, Amirhossein, Serban, Maria-Corina, Penson, Peter, Gurban, Camelia, Ursoniu, Sorin, Toth, Peter P., Jones, Steven R., Lippi, Giuseppe, Kotani, Kazuhiko, Kostner, Karam, Rizzo, Manfredi, Rysz, Jacek, Banach, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501893/ https://www.ncbi.nlm.nih.gov/pubmed/28573436 http://dx.doi.org/10.1007/s40265-017-0767-4 |
Ejemplares similares
-
A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations
por: Ursoniu, Sorin, et al.
Publicado: (2018) -
Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials
por: Ursoniu, Sorin, et al.
Publicado: (2015) -
Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials
por: Broncel, Marlena, et al.
Publicado: (2015) -
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015) -
The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
por: Maierean, Serban, et al.
Publicado: (2017)